Skip to main content

Advertisement

SpringerLink
Log in

Pathological Complete Response to Nivolumab, S1, Oxaliplatin, and Radiation in a Patient with Gastric Cancer: a Case Report

  • Published:
Journal of Gastrointestinal Cancer Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1
Fig. 2

Data Availability

No data available.

References

  1. Janjigian YY, Shitara K, Moehler M, Garrido M, Salman P, Shen L, et al. First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial. Lancet. 2021;398:27–40.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  2. Kang Y-K, Chen L-T, Ryu M-H, Oh D-Y, Oh SC, Chung HC, et al. Nivolumab plus chemotherapy versus placebo plus chemotherapy in patients with HER2-negative, untreated, unresectable advanced or recurrent gastric or gastro-oesophageal junction cancer (ATTRACTION-4): a randomised, multicentre, double-blind, placebo-controlled, phase 3 trial. Lancet Oncol. 2022;23:234–47.

    Article  CAS  PubMed  Google Scholar 

  3. Chubenko V, Inusilaev G, Imyanitov E, Moiseyenko V. Clinical case of the neoadjuvant treatment with nivolumab in a patient with microsatellite unstable (MSI-H) locally advanced gastric cancer. BMJ Case Rep. 2020;13: e236144.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Matsumoto R, Arigami T, Matsushita D, Okubo K, Tanaka T, Yanagita S, et al. Conversion surgery for stage IV gastric cancer with a complete pathological response to nivolumab: a case report. World J Surg Oncol. 2020;18:179.

    Article  PubMed  PubMed Central  Google Scholar 

Download references

Acknowledgements

We thank Dr. K Taniyama, Department of Pathology, Hiroshima Memorial Hospital, for the pathological diagnosis.

Author information

Authors and Affiliations

  1. Department of Surgery, Hiroshima Memorial Hospital, 1-4-3, Honkawa-Cho, Naka-Ku, Hiroshima, Hiroshima, 730-0802, Japan

    Kazuhiro Toyota, Yasushi Hashimoto, Yoshihiro Sakashita, Yujiro Yokoyama, Yoshiaki Murakami & Katsunari Miyamoto

  2. Department of Surgery, Graduate School of Biomedical and Health Sciences, Hiroshima University, Hiroshima, Japan

    Shinya Takahashi

Authors
  1. Kazuhiro Toyota
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Yasushi Hashimoto
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Yoshihiro Sakashita
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Yujiro Yokoyama
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. Yoshiaki Murakami
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Shinya Takahashi
    View author publications

    You can also search for this author in PubMed Google Scholar

  7. Katsunari Miyamoto
    View author publications

    You can also search for this author in PubMed Google Scholar

Contributions

All authors contributed to the study conception and design. The first draft of the manuscript was written by Kazuhiro Toyota. All authors reviewed the final manuscript.

Corresponding author

Correspondence to Kazuhiro Toyota.

Ethics declarations

Competing Interests

The authors declare no competing interests.

Inform Consent

All authors comply with the journal’s ethical policies. The authors affirm that the parent provided informed consent for publication of the images in Figs. 1A–F and 2A–C. Written informed consent was obtained from the parent. Informed consent was obtained from the patient for the publication of this report and any accompanying images. The authors declare no competing interests.

Additional information

Publisher's Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Rights and permissions

Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Toyota, K., Hashimoto, Y., Sakashita, Y. et al. Pathological Complete Response to Nivolumab, S1, Oxaliplatin, and Radiation in a Patient with Gastric Cancer: a Case Report. J Gastrointest Canc 54, 1000–1002 (2023). https://doi.org/10.1007/s12029-022-00895-z

Download citation

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12029-022-00895-z

Keywords

Search

Navigation